Indiana University innovations transform society through the commercialization process. In 2018, IU received 38 patents from the U.S. Patent and Trademark Office, ranking 63rd in the "Top 100 Worldwide Universities Granted U.S. Utility Patents 2018" report. Since 1997, IU research has generated nearly 3,200 inventions resulting in more than 4,800 global patent applications—important innovations that improve the economic strength of our state and the quality of life for all.
Moving research discoveries to the public
-
New award recognizes Bloomington faculty who boost campus diversity and inclusion
The Inclusive Excellence Award honors faculty who enhance a diverse campus community in accord with IU Bloomington's Statement on Diversity.
-
New self-administered digital health tool helps women assess their risk for premature delivery
PopNatal uses an innovate chatbot interface to screen and collect data to help women determine their risk for preterm birth.
-
From the Desk: Making life better for all Hoosiers, every day
IU Vice President for Research Fred Cate discusses the real and lasting difference IU has made through three Grand Challenge initiatives.
-
Newly created Wylie Innovation Catalyst Medal recognizes the past, encourages future IU innovators
IU President Michael A. McRobbie will award the medals to alumnus Jack Gill and alumnus and faculty member Richard DiMarchi.
-
IU delivers $9.9 billion impact on state, high return on investment for students and taxpayers
New study demonstrates the major impact IU continues to have in contributing to a prosperous, productive and innovative Indiana economy.
-
IU Ventures, IU ASEAN Gateway to host virtual event for alumni startups
The competitors for the Oct. 1 online event come from China, India, Indonesia, Myanmar, Malaysia, Singapore and Thailand.
-
Read about expanded access to LinkedIn Learning, an IU health expert's opinion about COVID-19 and more.
-
IU invests in 31 research projects exploring racial justice, announces gender equity task force
The Gender Equity in Research Task Force will explore the pandemic's impact on research productivity among IU researchers.
-
IU's pharmaceutical pipeline features innovative technologies for disease treatment
Thirty-six therapeutic technologies are under development to treat diseases, including two to fight against COVID-19.
-
Q&A with Nancy T. Chang, plenary speaker, Innovation and Commercialization Conference
Nancy T. Chang, founder of the biopharmaceutical company Tanox, will speak about developing research from her lab into a multibillion-dollar enterprise.